Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Harvard Business School
Julphar
Chubb
Moodys
Mallinckrodt
AstraZeneca
Queensland Health

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NIMBEX

« Back to Dashboard

Clinical Trials for Nimbex

Trial ID Title Status Sponsor Phase Summary
NCT01690338 A Study of Residual Curarization Incidence in China Unknown status Central South University Phase 4 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
NCT01690338 A Study of Residual Curarization Incidence in China Unknown status China Medical University Hospital Phase 4 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
NCT01690338 A Study of Residual Curarization Incidence in China Unknown status Chinese PLA General Hospital Phase 4 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Nimbex

Condition Name

Condition Name for Nimbex
Intervention Trials
Neuromuscular Blockade 3
Ankle Fracture 1
Paralysis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nimbex
Intervention Trials
Postoperative Complications 2
Respiratory Distress Syndrome, Newborn 2
Respiratory Distress Syndrome, Adult 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nimbex

Trials by Country

Trials by Country for Nimbex
Location Trials
United States 18
China 11
Czech Republic 1
Lebanon 1
Thailand 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nimbex
Location Trials
Massachusetts 1
Tennessee 1
Mississippi 1
New York 1
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nimbex

Clinical Trial Phase

Clinical Trial Phase for Nimbex
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nimbex
Clinical Trial Phase Trials
Recruiting 5
Completed 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nimbex

Sponsor Name

Sponsor Name for Nimbex
Sponsor Trials
China Medical University Hospital 1
Zhujiang Hospital 1
Peking Union Medical College Hospital 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nimbex
Sponsor Trials
Other 31
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Boehringer Ingelheim
Healthtrust
Moodys
Harvard Business School
Mallinckrodt
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.